Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study

OBJECTIVE: Neuronata-R® (lenzumestrocel) is an autologous bone marrow-derived mesenchymal stem cell (BM-MSC) product, which was conditionally approved by the Korean Ministry of Food and Drug Safety (KMFDS, Republic of Korea) in 2013 for the treatment of amyotrophic lateral sclerosis (ALS). In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Jae-Yong, Chun, Sehwan, Lee, Tae Yong, Seo, Yunjeong, Kim, Kwijoo, Park, Jinseok, Sung, Wonjae, Oh, Ki-Wook, Lee, Sanggon, Park, Jin-Sung, Oh, Juyeon, Chung, Kyung Cheon, An, Hyonggin, Chu, Hyeon Sik, Son, Bugyeong, Kim, Seung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130504/
https://www.ncbi.nlm.nih.gov/pubmed/37122380
http://dx.doi.org/10.3389/fnagi.2023.1148444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130504/
https://www.ncbi.nlm.nih.gov/pubmed/37122380
http://dx.doi.org/10.3389/fnagi.2023.1148444

Ejemplares similares